Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-02-01 @ 9:23 PM
Study NCT ID:
NCT00394693
Status:
COMPLETED
Last Update Posted:
2014-07-16
First Post:
2006-10-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma
Sponsor:
Transgene
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma, B-Cell | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Primary CBCL including (WHO/EORTC classification 2005) | View |
| None | Primary cutaneous marginal zone B-cell lymphoma | View |
| None | Primary cutaneous follicle center B-cell lymphoma | View |
| None | Primary cutaneous diffuse large B-cell other than leg type | View |
| None | Histologically consistent with primary CBCL | View |
| None | Relapse or active disease | View |